- Clinical Perspectives: Neoadjuvant and Adjuvant Therapies for Early-Stage HR+ Breast Cancer
- HR+/HER2- mBC: CDK4/6 Inhibitors and Post-CDK4/6 Space
- Role of ctDNA in Breast Oncology: MRD, Molecular Profiling and Beyond
- Tailoring Treatment for Early- and Advanced-Stage HER2+ Breast Cancer
- Improving Survival in TNBC with IO, ADCs and Novel Frontiers
- Live Q&A
OncLive® State of the Science Summit™ Breast Cancer
Hilton Boston Back Bay
40 Dalton St.
Boston, MA 02115
United States
March 26, 2025
6:00 PM-9:00 PM ET
In-Person Only
Event Chair
Paolo Tarantino, MD
Dana-Farber Cancer Institute
OVERVIEW
OncLive® State of the Science Summit™ (SOSS) are in-person meetings designed for academic & community-based physicians and health care professionals that provide education on the science driving updates in cancer management and the associated clinical benefits for patients. SOSS attendees will improve their knowledge of novel treatment approaches and reinforce their confidence in applying state-of-the-art treatment strategies.
Registration for this Summit is complimentary.
TOPICS INCLUDE:
Venue Location
Hilton Boston Back Bay40 Dalton St, Boston, MA, USA
OncLive - an MJH Life Sciences brand
Copyright 2025 (C) Intellisphere, LLC
2 Commerce Drive
Cranbury, NJ 08512